Completed NA INTERVENTIONAL 2-arm NCT02004847

Blue Light for Treating Psoriasis Vulgaris

Monocenter, Randomized, Double Blinded, Intraindividual, Exploratory Study of Effectiveness and Safety of 3 Months Treatment With 2 Peak Intensities of 453nm Blue Light for the Treatment of Mild Plaque Type Psoriasis Vulgaris

Sponsor: Philips Electronics Nederland BV

Conditions Psoriasis Vulgaris

Interventions PSO-CT02

Updated 7 times since 2017 Last updated: Nov 17, 2015 Started: Sep 30, 2013 Primary completion: May 31, 2014 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Psoriasis Vulgaris, this trial is completed. The trial is conducted by Philips Electronics Nederland BV and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
May 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — May 2019 [monthly]

Completed NA

▶ Show 2 earlier versions

May 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — May 2017 [monthly]

Completed NA

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Philips Electronics Nederland BV

Data source: Philips Electronics Nederland BV

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aachen, Germany